Suus Baggen
- A new class of bronchodilator improves lung function in COPD: a trial with GSK961081By Pascal L.M.L. Wielders, Andrea Ludwig-Sengpiel, Nicholas Locantore, Suus Baggen, Robert Chan and John H. RileyPascal L.M.L. Wielders1Dept of Pulmonary Diseases, Catharina Hospital, EindhovenAndrea Ludwig-Sengpiel2KLB Healthresearch Luebeck, Luebeck, GermanyNicholas Locantore3GlaxoSmithKline, Research Triangle Park, NC, USASuus Baggen4GlaxoSmithKline, Zeist, The NetherlandsRobert Chan5GlaxoSmithKline, Uxbridge, UKJohn H. Riley5GlaxoSmithKline, Uxbridge, UK
- A new class of bronchodilator improves lung function in COPD: a trial with GSK961081By Pascal LML Wielders, Andrea Ludwig-Sengpiel, Nicholas Locantore, Suus Baggen, Robert Chan and John H. RileyArticle | Published in 2013 in European Respiratory JournalPascal LML Wielders*Dept. of Pulmonary Diseases, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The NetherlandsAndrea Ludwig-Sengpiel#KLB Healthresearch Luebeck, Pferdemarkt 6-8, D-23552 Luebeck, GermanyNicholas Locantore¶GlaxoSmithKline, Research Triangle Park, North Carolina USASuus Baggen+GlaxoSmithKline, Zeist, The NetherlandsRobert Chan§GlaxoSmithKline, Stockley Park West, Uxbridge, UKJohn H. Riley§GlaxoSmithKline, Stockley Park West, Uxbridge, UK
- A new class of bronchodilator improves lung function in COPD: a trial with GSK961081By Pascal L.M.L Wielders, Andrea Ludwig-Sengpiel, Nicholas Locantore, Suus Baggen, Robert Chan and John H. RileyArticle | Published in 2013 in European Respiratory JournalPascal L.M.L Wielders*Dept. of Pulmonary Diseases, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The NetherlandsAndrea Ludwig-Sengpiel#KLB Healthresearch Luebeck, Pferdemarkt 6-8, D-23552 Luebeck, GermanyNicholas Locantore¶GlaxoSmithKline, Research Triangle Park, North Carolina USASuus Baggen+GlaxoSmithKline, Zeist, The NetherlandsRobert Chan§GlaxoSmithKline, Stockley Park West, Uxbridge, UKJohn H. Riley§GlaxoSmithKline, Stockley Park West, Uxbridge, UK
- A new class of bronchodilator improves lung function in COPD: a trial with GSK961081By Pascal L.M.L Wielders, Andrea Ludwig-Sengpiel, Nicholas Locantore, Suus Baggen, Robert Chan and John H. RileyArticle | Published in 2013 in European Respiratory JournalPascal L.M.L Wielders*Dept. of Pulmonary Diseases, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The NetherlandsAndrea Ludwig-Sengpiel#KLB Healthresearch Luebeck, Pferdemarkt 6-8, D-23552 Luebeck, GermanyNicholas Locantore¶GlaxoSmithKline, Research Triangle Park, North Carolina USASuus Baggen+GlaxoSmithKline, Zeist, The NetherlandsRobert Chan§GlaxoSmithKline, Stockley Park West, Uxbridge, UKJohn H. Riley§GlaxoSmithKline, Stockley Park West, Uxbridge, UK
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.